Simplex Trading
BCAX

Simplex Trading’s Bicara Therapeutics BCAX Stock Holding History

Simplex Trading’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9K Buy
+1,309
New +$29.2K ﹤0.01% 6537
2026
Q1 		– Sell
-4,167
Closed -$71.7K – 10404
2025
Q4 		$70.1K Buy
4,167
+3,159
+313% +$54K ﹤0.01% 5343
2025
Q3 		$15K Buy
+1,008
New +$11.3K ﹤0.01% 7611
2025
Q2 		– Sell
-154
Closed -$1.83K – 9955
2025
Q1 		$2K Buy
+154
New +$2.04K ﹤0.01% 8114

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's BCAX Position: Q2 2026 in Review

Simplex Trading opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 1,309 shares worth $38.9K. The stake represents ﹤0.01% of the portfolio and ranks #6537 among its holdings. This is a return to the name: Simplex Trading previously reported a position in BCAX as recently as Q4 2025.

Simplex Trading first reported a position in BCAX in Q1 2025 and has held it in 4 quarters since. The position peaked at $70.1K in Q4 2025. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Simplex Trading held 1,309 shares of Bicara Therapeutics worth $38.9K as of Q2 2026.
  • Bicara Therapeutics was a new Simplex Trading position in Q2 2026.
  • Bicara Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6537 holding.
  • Simplex Trading first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Simplex Trading's Bicara Therapeutics position peaked at $70.1K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.